LEO Pharma

LEO Pharma´s sustainability strategy rests on two pillars: Enabling Health and Responsible Business.

Enabling Health is purpose-driven and focuses on delivering LEO Pharma´s social value contribution. Responsible Business focuses on how we operate in an ethical and responsible way to ensure integrity and respect for our employees, business partners, and the environment

About LEO Pharma:

LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, and today, the company offers a wide range of therapies for all disease severities. LEO Pharma is headquartered in Denmark with a global team of 4,700 people, serving millions of patients across the world. In 2022, the company generated net sales of DKK 10.6 billion.

For more information, go to: www.linkedin.com/company/leo-pharma or www.leo-pharma.com


Industriparken 55, 2750 Ballerup, Danmark ,


Wojciech Valdemar Munk Klimko

ESG and Sustainability Advisor

Lærke Kristensen

ESG and Sustainability Manager

Seneste nyt

26.09.2019LEO Pharma


SDG solutions through partnerships

This week heads of state and business leaders from around the world meet in New York. The purpose is clear; everybody wants to find solutions on how to achieve the world’s greatest challenges, the UN Sustainable Development Goals (SDGs).

03.09.2019LEO Pharma


Reflecting our CSR commitment

Artikler virksomheden er nævnt i


‘We are on a new path and it is a good path’


Dilemmaer omkring bæredygtighed – indkøb skal gøre en forskel


26 topledere: Danmarks næste regering skal have fokus på Verdensmålene


Digital bæredygtighed kræver integritet

11.04.2017Dansk Erhverv


CSR: Tendenser og udfordringer- set med tre forskellige aktørers øjne